Results 231 to 240 of about 74,008 (304)

Sustained MRD‐Negative Complete Remission of T‐PLL With CNS Involvement Following Treatment With Systemic and Intrathecal Alemtuzumab

open access: yeseJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Background T‐cell prolymphocytic leukaemia (T‐PLL) with central nervous system (CNS) involvement is uncommon and evidence guiding its treatment is limited. Case summary We describe the successful treatment of T‐PLL with leptomeningeal involvement using intrathecal alemtuzumab followed by allogeneic haematopoietic stem cell transplantation ...
Isobel Rowe   +7 more
wiley   +1 more source

Cytogenotoxic Effects of Fluopyram in Allium cepa Root Cells Involving Microtubule Disruption

open access: yesEnvironmental Toxicology, Volume 41, Issue 12, Page 1688-1700, December 2026.
ABSTRACT Fluopyram is a next‐generation fungicide widely used in agriculture; however, its persistence in soils and mobility toward aquatic systems have raised concerns regarding potential ecotoxicological risks. This study evaluated the cytogenotoxic effects of a commercial fluopyram‐based pesticide formulation on Allium cepa root meristem cells ...
Carlos Filipe Camilo‐Cotrim   +10 more
wiley   +1 more source

Real-world outcomes for multiple myeloma patients after apheresis for planned chimeric antigen receptor T-cell therapy. [PDF]

open access: yesWorld J Exp Med
Bangolo A   +38 more
europepmc   +1 more source

Finding the genes that fit CPX-351. [PDF]

open access: yesBlood Adv
Hanamshet A, Othman J.
europepmc   +1 more source

Chronic Active Epstein–Barr Virus (EBV) Disease with Haemophagocytic Lymphohistiocytosis and Abnormal T/NK Cells

open access: yes
eJHaem, Volume 7, Issue 6, December 2026.
Buthaina Al Maashari   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy